Home
Conditions
Lymphoma, Non-Hodgkin

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Adapting Multiple Behavior Interventions That Effectively Improve Cancer Survivor Health Cancer Survivor Health

NCT04000880

Conditions: Adnexal Diseases, Behavior, Blood Protein Disorders, +67 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of Tennessee Health Science Center Memphis, Tennessee, United States

View Trial Details

Completed

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

NCT05653271

Conditions: B-cell Lymphoma, Burkitt Lymphoma, DLBCL, +23 more
Locations: AdventHealth Orlando Orlando, Florida, United States

Emory University Atlanta, Georgia, United States

Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States

Norton Cancer Institute Louisville, Kentucky, United States

View all 13 locations

View Trial Details

Completed

Molecular Imaging of Lymphoma Using Labeled Technetium-99m 1-Thio-D-Glucose

NCT04292626

Conditions: Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, Adult, +9 more
Locations: TomskNRMC Tomsk, Russia

View Trial Details

Completed

Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies

NCT04205409

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +46 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details

Completed

Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma

NCT05422521

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: CHU de Nice Nice, France

View Trial Details

Completed

Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma

NCT03570892

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Moores UC San Diego Cancer Center La Jolla, California, United States

University of California Los Angeles Los Angeles, California, United States

UCSF Medical Center San Francisco, California, United States

Sarah Cannon Research Institute Denver, Colorado, United States

View all 67 locations

View Trial Details

Completed

CAR-T for R/R B-NHL

NCT03196830

Conditions: CAR - T CD19/CD20/CD22/CD30, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations: the First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Completed

A Study of ASCT Bridging CART Cell Therapy in Relapsed/Refractory B-cell Lymphoma

NCT04923789

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Completed

A Study of CD19/22 CART Cells Combined With PD-1 Inhibitor in Relapsed/Refractory B-cell Lymphoma

NCT04539444

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
Locations: The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

View Trial Details

Completed

Low-Dose Selinexor and Choline Salicylate for Non-Hodgkin or Hodgkin Lymphoma, Histiocytic/Dendritic Cell Neoplasm, or Relapsed or Refractory Multiple Myeloma

NCT04640779

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +24 more
Locations: Mayo Clinic in Rochester Rochester, Minnesota, United States

View Trial Details

Lymphoma, Non-Hodgkin

Lymphoma, Non-Hodgkin trial results

Related conditions